Across TCGA pan-cancer cohorts, LINC01795 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01795’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC01795 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01795 is over-expressed in tumor.
LUSC and HNSC are the cancer types where LINC01795 tumor–normal differential expression is most reproducible.